In focus · trending topic

pharmaceutical treatments

1 stories · following the connections

RespireRx Pharmaceuticals Inc. Officers and Directors Elect to Forgive $2,356,733 of Past Due Cash Compensation and Receive Non-Qualified Stock Options to Reduce Balance Sheet Debt

By Nasdaq OMXDec 15, 2017, 2:00 PM UTC